Compare Visa Inc (V) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Visa Inc vs DENTSPLY SIRONA Inc — how do they compare? Visa Inc trades at $385.45 (market cap $704.20B), while DENTSPLY SIRONA Inc trades at $8.83 (market cap $1.73B). The key difference: Visa Inc is far larger — about 407.1× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays the higher dividend (5.04%). Which is the better fit depends on your goals — on Pluang, investors hold Visa Inc for 115 Days and DENTSPLY SIRONA Inc for 72 Days on average.
| V | XRAY | |
|---|---|---|
Market Cap | $704.20B | $1.73B |
Volume | 6,405,857 | 6,198,582 |
Sector | Financials | Health |
52-Week High | $384.14 | $14.68 |
52-Week Low | $295.52 | $8.52 |
Typical Hold Time | 115 Days | 72 Days |
Enterprise Value | $714.78B | $3.80B |
Dividend Yield | 0.71% | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Visa (V) trades at $375.10, up 0.81% today, with a bullish technical signal and strong analyst support. Recent quarterly earnings have consistently beaten expectations, with robust profitability margins and revenue growth. The company is expanding into AI-driven commerce and stablecoin payments, positioning for future growth. Cash flow from operations remains strong at $23.06 billion for 2025, supporting shareholder returns.
The outlook is positive with a consensus price target of $422.24, implying 12.6% upside. Risks include competitive fintech threats and regulatory pressures. Wall Street sentiment is overwhelmingly bullish, with 85% of analysts rating it a buy, but investors should monitor execution on AI initiatives and payment industry shifts.
DENTSPLY SIRONA (XRAY) trades at $8.69, down 1.76% on the day and near a 52-week low, reflecting ongoing operational challenges. The stock shows a bearish technical trend with weak moving averages, while fundamentals reveal declining revenue, negative net income margins, and elevated debt levels. Recent Q2 2026 earnings beat expectations but sales fell 4.1%, indicating persistent headwinds in dental markets.
The outlook remains cautious due to margin pressure and competitive threats, though analyst consensus suggests upside to a $13.40 price target. Key risks include execution of the turnaround plan, macroeconomic sensitivity, and high leverage. Investment appeal hinges on successful restructuring and recovery in core dental segments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Visa Inc
Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
